Farshad Hoseini Shirazi
Overview
Explore the profile of Farshad Hoseini Shirazi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zafari J, Rastegar-Pouyani N, Javani Jouni F, Najjar N, Azarshin S, Jafarzadeh E, et al.
Sci Rep
. 2024 Mar;
14(1):5792.
PMID: 38461218
Cisplatin is a chemotherapy drug widely used in cancer treatment. Alongside its clinical benefits, however, it may inflict intolerable toxicity and other adverse effects on healthy tissues. Due to the...
2.
Saffari M, Hoseini Shirazi F, Moghimi H
Iran J Pharm Res
. 2016 Dec;
15(3):261-267.
PMID: 27980561
Gene therapy is in its development stage as a novel method for cancer treatment. Liposomes look promising as gene delivery vectors; however, investigations have shown that these vesicles are not...
3.
Gholami S, Soleimani F, Hoseini Shirazi F, Touhidpour M, Mahmoudian M
Iran J Pharm Res
. 2013 Dec;
9(1):49-53.
PMID: 24363706
Mebudipine is a new dihydropyridine calcium channel blocker, synthesized in our laboratory, for treatment of hypertension. It has shown a better efficacy than other drugs in this group. For assessing...
4.
Saffari M, Tamaddon A, Hoseini Shirazi F, Oghabian M, Moghimi H
J Gene Med
. 2013 Jan;
15(1):12-9.
PMID: 23281182
Background: Liposomes are among the most widely used carriers for the delivery of antisense oligonucleotides (AsODNs) to intracellular targets. Although different strategies have been employed, the question of how to...
5.
Dadashzadeh S, Derakhshandeh K, Hoseini Shirazi F
Anticancer Drugs
. 2008 Aug;
19(8):805-11.
PMID: 18690092
The objective of this study was to evaluate the cytotoxicity and pharmacokinetics of total and lactone forms of 9-nitrocamptothecin (9-NC), an effective antineoplastic drug, after intravenous injection of drug incorporated...